Birth Control Pill Study CF111/303
This study is researching an investigational birth control pill. "Investigational" means that it is still being studied and has not been approved by the US FDA. This investigational pill does not contain estrogen and is being developed to reduce the risk of side effects associated with estrogen including venous thromboembolism.
The pill being tested in this study will be used for 13 menstrual cycles, approximately 1 year. We are trying to find out if this pill is likely to prevent pregnancy, is safe to use, and whether it causes any side effects. Women in this study should not use other methods of birth control during the study. Participation in this study requires 8 visits with bloodwork and physical exams.
• healthy, premenopausal women
• have regular menstrual periods
• not seeking pregnancy
• have a regular male sexual partner
Qualified participants will receive:
• study-related medical exams
• compensation for time and travel ($50-$150 per completed visit, a maximum of $775)
To view the informed consent document for this study, click here.
If you are interested in seeing if you qualify for this study, fill out the prescreening questionnaire here.
Dr. Kurt Barnhart, MD, MSCE
Laboratorios Leon Farma S.A.